2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial Infarction

Citations

WEB OF SCIENCE

27
Citations

SCOPUS

27

초록

Clinical practice guidelines published by the European Society of Cardiology and the American College of Cardiology/American Heart Association summarize the available evidence and provide recommendations for health professionals to enable appropriate clinical decisions and improve clinical outcomes for patients with acute myocardial infarction (AMI). However, most current guidelines are based on studies in non-Asian populations in the pre-percutaneous coronary intervention (PCI) era. The Korea Acute Myocardial Infarction Registry is the first nationwide registry to document many aspects of AMI from baseline characteristics to treatment strategies. There are well-organized ongoing and published randomized control trials especially for antiplatelet therapy among Korean patients with AMI. Here, members of the Task Force of the Korean Society of Myocardial Infarction review recent published studies during the current PCI era, and have summarized the expert consensus for the pharmacotherapy of AMI.

키워드

Myocardial infarction; Drug therapy; ST-SEGMENT-ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY; CONVERTING ENZYME-INHIBITORS; TYPE-1 RECEPTOR BLOCKERS; STATIN THERAPY; UNFRACTIONATED HEPARIN; CARDIOVASCULAR EVENTS; FIBRINOLYTIC THERAPY; PRIMARY ANGIOPLASTY
제목
2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial Infarction
저자
Kim, Hyun Kuk; Ahn, Youngkeun; Chang, Kiyuk; Jeong, Young-Hoon; Hahn, Joo-Yong; Choo, Eun Ho; Kim, Min Chul; Kim, Hyo-Soo; Kim, Weon; Cho, Myeong-Chan; Jang, Yangsoo; Kim, Chong Jin; Jeong, Myung Ho; Chae, Shung Chull
DOI
10.4070/kcj.2020.0196
발행일
2020-10
유형
Review
저널명
Korean Circulation Journal
권
50
호
10
페이지
845 ~ 866

파일 다운로드

Thumbnail